10-Q: Mobix Labs Faces Going Concern Doubt Amidst Mounting Losses
Quarterly Report
Mobix Labs, Inc. reported a significant net loss for the nine months ended June 30, 2025, raising substantial doubt about its ability to continue as a going concern beyond the next ninety days.
Summary
- Net revenue for the nine months ended June 30, 2025, increased by 130% to $8.03 million, up from $3.49 million in the prior year, primarily driven by recent acquisitions.
- Gross profit also saw a substantial increase of 361% to $4.06 million for the nine months ended June 30, 2025, compared to $0.88 million in the prior year.
- Despite revenue growth, the company incurred a net loss of $30.40 million for the nine months ended June 30, 2025, a 258% increase from $8.50 million in the prior year.
- Operating losses for the nine months ended June 30, 2025, were $30.53 million, a slight improvement from $35.18 million in the prior year.
- The cash balance decreased to $0.24 million as of June 30, 2025, from $0.27 million at September 30, 2024.
- The working capital deficit widened to $23.02 million as of June 30, 2025, from $20.84 million at September 30, 2024.
- Management identified material weaknesses in its internal control over financial reporting, including insufficient accounting personnel and ineffective risk assessment.
- Mobix Labs received a Nasdaq delinquency notice for failing to maintain a minimum bid price of $1.00 per share, with a compliance deadline of October 27, 2025.
Sentiment
Score: 2
Explanation: The company is in a precarious financial position, marked by substantial net losses, a widening accumulated deficit, and a critical lack of liquidity, leading to a going concern warning. While revenue growth is positive, it is overshadowed by severe operational and financial control weaknesses, and the risk of Nasdaq delisting. Recent capital raises are short-term fixes for immediate liquidity needs rather than long-term solutions.
Positives
- Net revenue for the nine months ended June 30, 2025, increased by 130% to $8.03 million, primarily due to the acquisitions of RaGE Systems and EMI Solutions.
- Gross profit for the nine months ended June 30, 2025, increased by 361% to $4.06 million.
- Operating loss for the nine months ended June 30, 2025, decreased by 13% to $30.53 million compared to the prior year.
- Regained compliance with Nasdaq's Market Value of Listed Securities (MVLS) requirement on May 20, 2025.
Negatives
- Incurred a significant net loss of $30.40 million for the nine months ended June 30, 2025, a 258% increase from the prior year.
- Accumulated deficit reached $134.86 million as of June 30, 2025.
- Working capital deficit widened to $23.02 million as of June 30, 2025.
- Cash balance is critically low at $0.24 million as of June 30, 2025.
- Substantial doubt exists regarding the company's ability to continue as a going concern beyond approximately ninety days.
- Received a Nasdaq delinquency notice for failing to maintain a minimum bid price of $1.00 per share, risking delisting if compliance is not met by October 27, 2025.
- Identified material weaknesses in internal control over financial reporting, indicating significant deficiencies in financial processes and personnel.
- Recognized an impairment loss of $725 thousand on long-lived assets due to vacating a leased office.
- Interest expense for the three months ended June 30, 2025, increased by 331% to $0.55 million due to higher outstanding borrowings and interest rates.
Risks
- Inability to timely regain compliance with Nasdaq listing requirements, including the $1.00 minimum bid price, potentially leading to delisting.
- Inability to meet future capital requirements and the risk of being unable to raise additional capital on attractive terms or at all, which could lead to dilution for existing stockholders or inability to continue operations.
- Risk of not successfully commercializing products and solutions or experiencing significant delays in doing so.
- Inability to generate sufficient income from operations to sustain the business.
- Risks concerning the ability to continue as a going concern.
- Difficulties in managing growth and expanding operations.
- Risk of not consummating planned strategic acquisitions or fully realizing anticipated benefits from past or future acquisitions or investments.
- Potential for litigation to be commenced against the company.
- Risk that patent applications may not be approved or may take longer than expected, and incurring substantial costs in enforcing and protecting intellectual property.
- Reliance on a limited number of customers and challenges in diversifying the customer base.
- Volatility in the price of securities due to a variety of factors, including changes caused by tariffs, competitive industries, global supply chain, macro-economic and social environments, and changes in capital structure.
- Potential amplification of risks by geopolitical tensions.
Future Outlook
The company expects to continue incurring operating losses and negative cash flows for the foreseeable future, necessitating additional debt or equity financing to fund operations and satisfy obligations. Management believes there is substantial doubt about the company's ability to continue as a going concern beyond approximately ninety days. The company is assessing the impact of the recently signed One Big Beautiful Bill Act (OBBBA) on its operations and financial statements.
Management Comments
- "We expect to continue to incur operating losses and negative cash flows from operations for the foreseeable future and will need to raise additional debt or equity financing to fund our operations and satisfy our obligations."
- "Management believes that there is substantial doubt concerning the Company's ability to continue as a going concern as the Company currently does not have adequate liquidity to meet its operating needs and satisfy its obligations beyond the next approximately ninety days."
- "We have begun an implementation plan to remediate these material weaknesses, which we expect will result in significant future costs for us."
- "Our management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the periods presented."
Industry Context
Mobix Labs operates in the rapidly evolving wireless and wired connectivity, RF, switching, and EMI filtering technology markets, serving consumer, commercial, industrial, automotive, medical, aerospace, and defense sectors. The company's strategy involves expanding its product portfolio through acquisitions, such as EMI Solutions and RaGE Systems, to enhance expertise in 5G communications, mmWave imaging, and software-defined radio, addressing increasing demand for higher performance communication and filtering systems. The industry is characterized by a continuous need for faster, more reliable data transmission, driving demand for advanced semiconductor components and solutions.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Officer/Director (previously) | Fabrizio Battaglia | NA | 2025-07-25 | Retirement and Release Agreement. |
| Director/Officer | NA | Frederick Goerner | 2025-08-11 | Granted Class B Restricted Stock Awards, indicating continued or new significant role. |
| Director/Officer | NA | James Peterson | 2025-08-11 | Granted Class B Restricted Stock Awards, indicating continued or new significant role. |
| President and Chief Financial Officer | NA | Keyvan Samini | 2025-08-11 | Granted Class B Restricted Stock Awards, indicating continued significant role. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Bylaws/Certificate of Incorporation | Adopted amended and restated certificate of incorporation and amended and restated bylaws in connection with the Merger, authorizing preferred stock, Class A Common Stock, and Class B Common Stock. | 2023-12-21 | Restructured capital stock and governance framework post-Merger. |
| Equity Incentive Plans | Adopted the 2023 Employee Stock Purchase Plan and the 2023 Equity Incentive Plan. | 2023-12-21 | Established new frameworks for stock-based compensation for employees and directors. |
| Indemnification Agreements | Entered into indemnification agreements with each of its directors and officers. | 2023-12-21 | Provides protection to directors and officers against certain liabilities. |
| Internal Control Deficiencies | Identified material weaknesses in internal control over financial reporting, including insufficient accounting personnel, ineffective risk assessment, and lack of formal accounting policies/procedures/controls. | 2025-06-30 | Indicates significant deficiencies in financial reporting processes, requiring substantial remediation efforts and costs. |
Legal Proceedings
- The company does not believe it is currently a party to any material legal proceedings, nor is it aware of any other pending or threatened litigation that would have a material adverse effect on its business, operating results, cash flows, or financial condition.
Related Party Transactions
- Two outstanding 7% promissory notes with related parties, assumed in 2020, with principal balances of $1.21 million (due through September 2026) and $1.17 million (due through March 2027, with $979 thousand principal due May 15, 2027).
- Entered into an operating lease with a related party for a 6,149 square foot facility in Irvine, California, effective October 1, 2024, with monthly rent payments of $12 thousand.
- One note payable to a related party with a principal balance of $330 thousand was repaid in April 2025.
Stakeholder Impact
- Shareholders: Significant dilution risk from future equity raises, potential loss of investment due to going concern doubt, and risk of delisting from Nasdaq.
- Employees: Workforce and cost reduction actions taken during fiscal year ended September 30, 2024, may impact employee morale and retention. Stock-based compensation is a significant component of compensation.
- Customers: Potential impact on product availability or support if liquidity issues persist or operations are curtailed.
- Creditors: Increased risk due to the company's going concern doubt and widening working capital deficit, although some debt has been settled with equity.
- Suppliers/Vendors: Risk of delayed payments or renegotiated terms due to liquidity constraints.
Next Steps
- Regain compliance with Nasdaq's minimum bid price requirement by October 27, 2025.
- Implement a remediation plan for identified material weaknesses in internal control over financial reporting, which is expected to incur significant future costs.
- Seek additional debt or equity financing to fund operations and satisfy obligations.
- Continue to pursue acquisitions of companies and technologies to enhance product portfolio and expand into strategically aligned industries.
- Assess the impact of the One Big Beautiful Bill Act (OBBBA) on operations and consolidated financial statements.
Key Dates
| Date | Description |
|---|---|
| 2022-11-15 | Original Business Combination Agreement date. |
| 2023-12-18 | Acquisition of EMI Solutions, Inc. completed. |
| 2023-12-19 | Sponsor PIPE Subscription Agreement entered into. |
| 2023-12-20 | Sponsor Letter Agreement and Non-Redemption Agreement entered into. |
| 2023-12-21 | Merger consummated; Chavant Capital Acquisition Corp. changed name to Mobix Labs, Inc.; Legacy Mobix changed name to Mobix Labs Operations, Inc.; common stock and public warrants began trading on Nasdaq. |
| 2024-05-21 | Acquisition of RaGE Systems, Inc. completed. |
| 2024-07-22 | Securities Purchase Agreement for Private Placement entered into. |
| 2024-07-24 | Issued unregistered pre-funded warrant and PIPE Common Warrants in Private Placement. |
| 2024-08-30 | Specified adjustment period for Make-Whole Shares ended; 1,052,029 Class A Common Stock shares issued in settlement. |
| 2024-10-01 | Effective date for operating lease with a related party for Irvine facility. |
| 2024-10-27 | Deadline to regain Nasdaq Minimum Bid Price Requirement compliance. |
| 2024-11-01 | Maturity date for a $330 thousand related party note payable (repaid April 2025). |
| 2025-01-03 | Stockholder approval obtained for PIPE investor warrants and Placement Agent Warrants to become exercisable. |
| 2025-03-01 | Company vacated a leased 19,436 sq ft office in Irvine, California. |
| 2025-03-25 | Entered into operating lease for new corporate headquarters in Irvine, California. |
| 2025-04-01 | Lease for Irvine office terminated. |
| 2025-04-04 | Entered into securities purchase agreement for April 2025 Offering. |
| 2025-04-07 | Issued 3,850,000 shares of Class A common stock and a pre-funded warrant in Registered Direct Offering. |
| 2025-04-10 | Issued 166,875 Class A Common Stock shares to a creditor in debt settlement. |
| 2025-04-28 | Received Nasdaq delinquency notification letters for MVLS and Minimum Bid Price requirements. |
| 2025-05-09 | Issued 79,709 Class A Common Stock shares to RaGE Systems stockholders as partial earnout settlement. |
| 2025-05-20 | Received letter from Nasdaq confirming compliance with MVLS Requirement. |
| 2025-05-25 | Entered into new lease for Newburyport, Massachusetts facility. |
| 2025-05-30 | Stockholder approval obtained for Common Warrants and amended PIPE Common Warrants to become exercisable; also for Class B RSAs grant. |
| 2025-06-30 | End of current reporting period. |
| 2025-07-04 | United States President Donald J. Trump signed the One Big Beautiful Bill Act (OBBBA) into law (effective date for some provisions). |
| 2025-07-25 | Retirement and Release Agreement with Fabrizio Battaglia signed. |
| 2025-08-11 | Granted 915,033 Class B RSAs to Frederick Goerner, James Peterson, and Keyvan Samini. |
| 2026-03-01 | Potential end date for RaGE Earnout payments. |
| 2026-09-01 | Maturity date for one 7% promissory note with related party. |
| 2027-05-15 | Remaining principal of $979 thousand on another 7% promissory note with related party due. |
| 2027-08-31 | Latest lease expiration date. |
| 2030-01-03 | Expiration date for Series A Warrants and Placement Agent Warrants. |
| 2030-04-03 | Extended expiration date for Series B Warrants. |
| 2030-05-30 | Expiration date for Common Warrants. |
Recommendation
strong sellMobix Labs faces severe financial distress, evidenced by a substantial net loss of $30.40 million for the nine months ended June 30, 2025, a widening accumulated deficit of $134.86 million, and a critically low cash balance of $0.24 million. Management has explicitly stated "substantial doubt" about the company's ability to continue as a going concern beyond the next ninety days, indicating imminent liquidity challenges. The company also has material weaknesses in internal controls, suggesting fundamental issues in financial management and reporting. Furthermore, the risk of Nasdaq delisting due to the minimum bid price requirement adds significant uncertainty and could further impair liquidity and investor confidence. While revenue has grown due to acquisitions, the inability to translate this into profitability and the ongoing need for dilutive capital raises make the stock a high-risk investment with significant downside potential.
Keywords
Mobix Labs, MOBX, SEC Filing, 10-Q, Quarterly Report, Wireless Connectivity, RF Technology, EMI Filtering, Semiconductors, 5G Communications, mmWave Imaging, Software Defined Radio, Active Optical Cables, AOCs, Financial Results, Going Concern, Nasdaq Delisting, Capital Raise, Internal Control Weaknesses, Acquisitions, RaGE Systems, EMI Solutions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.